A detailed history of Aureus Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Aureus Asset Management, LLC holds 2,394 shares of NVO stock, worth $209,163. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,394
Previous 2,475 3.27%
Holding current value
$209,163
Previous $353,000 19.26%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $9,644 - $11,779
-81 Reduced 3.27%
2,394 $285,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $104,490 - $229,271
1,149 Added 86.65%
2,475 $225,000
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $175,482 - $211,019
1,326 New
1,326 $211,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Aureus Asset Management, LLC Portfolio

Follow Aureus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.